Youliang Xie

985 total citations
31 papers, 827 citations indexed

About

Youliang Xie is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Youliang Xie has authored 31 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Immunology and 6 papers in Pharmacology. Recurrent topics in Youliang Xie's work include Phytochemical compounds biological activities (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Inflammatory Bowel Disease (4 papers). Youliang Xie is often cited by papers focused on Phytochemical compounds biological activities (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Inflammatory Bowel Disease (4 papers). Youliang Xie collaborates with scholars based in China, Hong Kong and Macao. Youliang Xie's co-authors include Ziren Su, Zhi‐Xiu Lin, Jianhui Xie, Chang Qu, Xie Zhang, Xiao‐Ping Lai, Jiangtao Zhou, Yaoxing Dou, Yanfeng Huang and Lieqiang Xu and has published in prestigious journals such as Journal of Ethnopharmacology, BioMed Research International and Toxicology.

In The Last Decade

Youliang Xie

27 papers receiving 819 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youliang Xie China 16 425 114 103 95 94 31 827
Krishan Kumar Thakur India 17 666 1.6× 159 1.4× 101 1.0× 112 1.2× 72 0.8× 24 1.4k
Lieqiang Xu China 16 373 0.9× 189 1.7× 87 0.8× 81 0.9× 48 0.5× 23 797
Yitao Wang Macao 15 452 1.1× 190 1.7× 56 0.5× 62 0.7× 74 0.8× 17 814
Jiazhen Wu China 19 436 1.0× 188 1.6× 65 0.6× 75 0.8× 90 1.0× 39 934
Ramesh B. Kasetti United States 23 632 1.5× 113 1.0× 57 0.6× 112 1.2× 47 0.5× 39 1.7k
Xingtao Zhao China 17 512 1.2× 147 1.3× 90 0.9× 107 1.1× 48 0.5× 33 1.1k
Kausik Bishayee South Korea 19 543 1.3× 121 1.1× 52 0.5× 95 1.0× 51 0.5× 38 1.1k
Jieun Shin South Korea 18 510 1.2× 207 1.8× 107 1.0× 119 1.3× 45 0.5× 59 1.1k
Jagan M.R. Patlolla United States 19 796 1.9× 90 0.8× 89 0.9× 71 0.7× 114 1.2× 34 1.5k
Ashwin A. Dihal Netherlands 12 371 0.9× 57 0.5× 128 1.2× 98 1.0× 53 0.6× 14 863

Countries citing papers authored by Youliang Xie

Since Specialization
Citations

This map shows the geographic impact of Youliang Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youliang Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youliang Xie more than expected).

Fields of papers citing papers by Youliang Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youliang Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youliang Xie. The network helps show where Youliang Xie may publish in the future.

Co-authorship network of co-authors of Youliang Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Youliang Xie. A scholar is included among the top collaborators of Youliang Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youliang Xie. Youliang Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Qiting, Weixiong Lin, Xiaoyan Shen, et al.. (2025). A Hepatic Oxidative Metabolite of Palmatine Ameliorates DSS-Induced Ulcerative Colitis by Regulating Macrophage Polarization Through AMPK/NF-κB Pathway. The American Journal of Chinese Medicine. 53(1). 285–307. 3 indexed citations
2.
Lin, Guosheng, Ziwei Xu, Shangping Xing, et al.. (2025). Proteomic screening identifies brusatol targets TGFβRII to suppresses non-small cell lung cancer metastasis. Phytomedicine. 139. 156468–156468.
3.
Xu, Ying, Li Chen, Xiaoxia Hu, et al.. (2025). Brusatol ameliorates intestinal mucosal injury in ulcerative colitis via activating IL-22/STAT3 pathway. International Immunopharmacology. 153. 114482–114482. 3 indexed citations
4.
Hu, Xiaoxia, Li Chen, Di Wang, et al.. (2025). Therapeutic Effect of Brucea Javanica Oil Emulsion in Mice with Irinotecan-Induced Delayed Diarrhea. Drug Design Development and Therapy. Volume 19. 5329–5347.
5.
Zhang, Yong, Xiaoxia Hu, Minghui Wu, et al.. (2025). Palmatine ameliorates intestinal epithelial barrier injury in ulcerative colitis via targeting enolase 3. International Immunopharmacology. 162. 115110–115110.
6.
Li, Minhua, Ziwei Huang, Gaoxiang Ai, et al.. (2023). Self-Assembled nanoparticles Combining Berberine and Sodium Taurocholate for Enhanced Anti-Hyperuricemia Effect. International Journal of Nanomedicine. Volume 18. 4101–4120. 7 indexed citations
7.
Li, Jiang, et al.. (2022). Reineckia carnea Alleviates the Production of Inflammatory Cytokines and MUC5AC in Rats with Chronic Obstructive Pulmonary Disease. Evidence-based Complementary and Alternative Medicine. 2022. 1–8. 1 indexed citations
8.
Qu, Chang, Qiaoping Li, Ziren Su, et al.. (2021). Nano-Honokiol ameliorates the cognitive deficits in TgCRND8 mice of Alzheimer’s disease via inhibiting neuropathology and modulating gut microbiota. Journal of Advanced Research. 35. 231–243. 62 indexed citations
9.
Xu, Ying, et al.. (2021). Brusatol‐Enriched Brucea javanica Oil Ameliorated Dextran Sulfate Sodium‐Induced Colitis in Mice: Involvement of NF‐κB and RhoA/ROCK Signaling Pathways. BioMed Research International. 2021(1). 5561221–5561221. 11 indexed citations
11.
Long, Yang, Siyuan Tan, Qiang Han, et al.. (2020). Efficient water-mediated synthesis of bismuth oxyiodide with several distinct morphologies. CrystEngComm. 22(10). 1754–1761. 4 indexed citations
12.
Tong, Lin, Wenwei Luo, Ziqing Li, et al.. (2020). Rhamnocitrin extracted from Nervilia fordii inhibited vascular endothelial activation via miR-185/STIM-1/SOCE/NFATc3. Phytomedicine. 79. 153350–153350. 17 indexed citations
14.
Dou, Yaoxing, Jiangtao Zhou, Tongtong Wang, et al.. (2018). Self-nanoemulsfiying drug delivery system of bruceine D: a new approach for anti-ulcerative colitis. International Journal of Nanomedicine. Volume 13. 5887–5907. 52 indexed citations
15.
Zhou, Jiangtao, Lihua Tan, Jianhui Xie, et al.. (2017). Characterization of brusatol self-microemulsifying drug delivery system and its therapeutic effect against dextran sodium sulfate-induced ulcerative colitis in mice. Drug Delivery. 24(1). 1667–1679. 65 indexed citations
16.
Huang, Qionghui, Lieqiang Xu, Yuhong Liu, et al.. (2017). Polydatin Protects Rat Liver against Ethanol‐Induced Injury: Involvement of CYP2E1/ROS/Nrf2 and TLR4/NF‐κB p65 Pathway. Evidence-based Complementary and Alternative Medicine. 2017(1). 7953850–7953850. 60 indexed citations
17.
Huang, Yanfeng, Jiangtao Zhou, Chang Qu, et al.. (2017). Anti-inflammatory effects of Brucea javanica oil emulsion by suppressing NF-κB activation on dextran sulfate sodium-induced ulcerative colitis in mice. Journal of Ethnopharmacology. 198. 389–398. 64 indexed citations
18.
Xu, Lieqiang, Youliang Xie, Xie Zhang, et al.. (2016). Polydatin attenuatesd-galactose-induced liver and brain damage through its anti-oxidative, anti-inflammatory and anti-apoptotic effects in mice. Food & Function. 7(11). 4545–4555. 122 indexed citations
19.
Huang, Mingqing, Youliang Xie, Xiao‐Ping Lai, et al.. (2012). Protection of Total Flavonoid Fraction from Nervilia fordii on Lipopolysaccharide-induced Acute Lung Injury in Rats. Chinese Herbal Medicines. 4(4). 287–293. 1 indexed citations
20.
Xie, Youliang, et al.. (2010). In vivo treatment for Friend murine leukemia virus with ganoderma spore oil.. Zhongcaoyao. 41(3). 423–426. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026